创新医疗(002173.SZ)：签署参股公司全诊医学《B+轮增资协议》《B+轮股东协议》及相关文件

Group 1 - The core point of the news is that QuanZhen Medical is conducting a B+ round financing to support its business development, with investments from three entities: Puhua Zhongxiao, Changzhou Hengnuo, and the Talent Fund [1] - The board of QuanZhen Medical has approved the signing of the B+ round capital increase agreement and related documents, resulting in the company's stake being 16.5160% after the financing [1] Group 2 - According to the B+ round capital increase agreement, Puhua Zhongxiao will invest RMB 20 million, acquiring 7.1429% equity in QuanZhen Medical, while Changzhou Hengnuo and the Talent Fund will each invest RMB 5 million, acquiring 1.7857% equity [2] - The registered capital of QuanZhen Medical will increase to RMB 1,652.8106 million following this financing round [2]